title: Cross-resistance of the gemcitabine resistant human ovarian cancer cell line AG6000 to standard and investigational drugs.
authors.affiliation: Department of Medical Oncology, Free University Hospital, Amsterdam, The Netherlands.
authors.forename: A M
authors.initials: AM
authors.lastname: Bergman
authors.forename: H M
authors.initials: HM
authors.lastname: Pinedo
authors.forename: V W
authors.initials: VW
authors.lastname: Ruiz van Haperen
authors.forename: G
authors.initials: G
authors.lastname: Veerman
authors.forename: C M
authors.initials: CM
authors.lastname: Kuiper
authors.forename: G J
authors.initials: GJ
authors.lastname: Peters
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000633:toxicity*; D000970:Antineoplastic Agents / Q000633:toxicity*; D002455:Cell Division / Q000187:drug effects; D002999:Clone Cells; D004249:DNA Damage; D003841:Deoxycytidine / Q000031:analogs & derivatives* / Q000633:toxicity; D019008:Drug Resistance, Neoplasm; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms; D014407:Tumor Cells, Cultured; D000093542:Gemcitabine
chemical_list: D000964:Antimetabolites, Antineoplastic; D000970:Antineoplastic Agents; D003841:Deoxycytidine; D000093542:Gemcitabine